Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

Study to Evaluate the Effect of Multiple-Dose Ritlecitinib on the Pharmacokinetics (PK) of TolbutamideCompleted
NCT05097716Phase 1Updated Oct 6, 2023
Sponsor: Pfizer
Healthy Volunteers
United States
Food Effect Study to Evaluate the Effect of High-Fat Meal on the Relative Bioavailability of PF-07321332 Boosted With Ritonavir in Healthy Adult ParticipantsCompleted
NCT05129475Phase 1Updated Oct 5, 2023
Sponsor: Pfizer
Healthy Participants
United States
Drug-Drug Interaction Study to Estimate the Effect of PF-07321332/Ritonavir and Ritonavir on Midazolam in Healthy ParticipantsCompleted
NCT05032950Phase 1Updated Oct 4, 2023
Sponsor: Pfizer
Healthy Participants
Belgium
Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale CanadaRecruiting
NCT02009345N/AUpdated Oct 4, 2023
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Familial Hypercholesterolemia · Lipid Disorder
Canada
A COHORT STUDY TO EVALUATE IMMUNOGENICITY FOR CHINESE CHILDREN AT THE TIME OF CLINICAL PNEUMONIA DIAGNOSISCompleted
NCT05372575NAUpdated Oct 3, 2023
Sponsor: Pfizer
Immunogenicity, Vaccine
China
A Study To Describe The Real World Use Of Bosutinib In The UK And NetherlandsCompleted
NCT02546375N/AUpdated Oct 3, 2023
Sponsor: Pfizer
Chronic Myeloid Leukaemia
United Kingdom
A Study To Estimate The Effect of PF-06650833 On The Pharmacokinetics (PK) of Oral Contraceptive (OC)Completed
NCT05064332Phase 1Updated Oct 2, 2023
Sponsor: Pfizer
Healthy
United States
A Study To Investigate And Describe The Treatment Patterns And Effect Of Tofacitinib Indicators For Patients With Rheumatoid ArthritisCompleted
NCT04721808N/AUpdated Sep 29, 2023
Sponsor: Pfizer
Arthritis, Rheumatoid
United States
Ramipril for the Treatment of COVID-19Completed
NCT04366050Phase 2Updated Sep 28, 2023
Sponsor: University of California, San Diego
COVID-19
United States
Prospective Study of the Prognostic Value of New Markers in Adults With ALK-positive Large Anaplastic LymphomaCompleted
NCT03603847N/AUpdated Sep 26, 2023
Sponsor: The Lymphoma Academic Research Organisation
Anaplastic Large Cell Lymphoma, ALK-Positive
France
Long Term Use of Somavert (Pegvisomant) For A Regulatory Post Marketing Commitment PlanCompleted
NCT00658879N/AUpdated Sep 25, 2023
Sponsor: Pfizer
Acromegaly
Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid TumorsTerminated
NCT03565991Phase 2Updated Sep 25, 2023
Sponsor: Pfizer
Locally Advanced or Metastatic Solid Tumors · Genes, BRCA 1
United States, Belgium, Denmark, France, Italy +4 more
Acute Treatment Trial in Adult Subjects With MigrainesCompleted
NCT03872453Phase 2, Phase 3Updated Sep 25, 2023
Sponsor: Pfizer
Migraine
United States
Special Investigation Of Genotropin Long Follow-Up For Patients With A Small For Gestational Age "Scoped for Japanese"Completed
NCT01897766N/AUpdated Sep 25, 2023
Sponsor: Pfizer
Small for Gestational Age (SGA)
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of PF-06649751 in Subjects With Idiopathic Parkinson's DiseaseCompleted
NCT02373072Phase 1Updated Sep 22, 2023
Sponsor: Pfizer
Idiopathic Parkinson Disease
United States, Belgium
A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular TumorsTerminated
NCT02110069Phase 2Updated Sep 21, 2023
Sponsor: Boston Children's Hospital
Kaposiform Hemangioendothelioma (KHE) · Kasabach-Merritt Syndrome · Tufted Angioma
United States
Hemolysis Related Complications in SCD. A Phase II Study With VoxelotorUnknown
NCT05199766Phase 2Updated Sep 21, 2023
Sponsor: Assistance Publique - Hôpitaux de Paris
Sickle Cell Disease
France
Safety Study of Continued Enzalutamide Treatment In Prostate Cancer PatientsCompleted
NCT01995513Phase 4Updated Sep 18, 2023
Sponsor: Pfizer
Prostate Cancer
United States, Australia, Belgium, Denmark, Finland +6 more
Safety And Efficacy Of Lyrica (Regulatory Post Marketing Commitment Plan)Completed
NCT01256593N/AUpdated Sep 15, 2023
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Neuralgia
A Study In Adults With Moderate To Severe DermatomyositisCompleted
NCT03181893Phase 2Updated Sep 14, 2023
Sponsor: Pfizer
Dermatomyositis
United States, Germany, Hungary, Poland, Spain
Safety, Tolerability, Pharmacokinetics, and Food Effect Study of RV299 in Healthy AdultsCompleted
NCT06033612Phase 1Updated Sep 13, 2023
Sponsor: Pfizer
Respiratory Syncytial Virus Infections
United Kingdom
PCV13 Impact on Pneumococcal Nasopharyngeal Carriage StudyUnknown
NCT05114902N/AUpdated Sep 13, 2023
Sponsor: Asian Foundation for Tropical Medicine Inc.
Community-acquired Pneumonia
Philippines
Safety of Dexmedetomidine in Severe Traumatic Brain InjuryWithdrawn
NCT01007773Phase 2Updated Sep 13, 2023
Sponsor: University of Maryland, Baltimore
Traumatic Brain Injury
United States
Dose, Safety, and Pathogenicity of a New Influenza H1N1 Challenge StrainCompleted
NCT05572450NAUpdated Sep 13, 2023
Sponsor: Hvivo
Influenza A H1N1
United Kingdom
Prevenar13 Drug Use Investigation - Adults Aged 65 Years or Older-Completed
NCT03014206N/AUpdated Sep 13, 2023
Sponsor: Pfizer
Adult Not Younger Than 65 Years
Japan

Previous page Next page